Lucy DesJardin Email

Director Translational Research . TuHURA Biosciences

Current Roles

Employees:
28
Revenue:
$4.3M
About
TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.
TuHURA Biosciences Address

Tampa, FL
United States
TuHURA Biosciences Email

Past Companies

Morphogenesis, Inc.Director of Translational Research
State Hygienic Laboratory at the University of IowaProgram Manager for Research and Development
University of IowaDepartment of Medicine